Skip to content

Clinical trials

Completed Phase 3 Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disease Phase: Phase 3 Status: Completed Clear all

51 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20013
20023
20044
20056
20063
20071
20082
20095
20102
20121
20143
20152
20162
20171
20181
20192
20204
20223
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed51

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ontario Clinical Oncology Group (OCOG)4
Blue Earth Diagnostics3
Eisai Inc.3
Assistance Publique - Hôpitaux de Paris2
Eli Lilly and Company2
Fondazione EMN Italy Onlus2
GlaxoSmithKline2
Lyra Therapeutics2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2
University of Sao Paulo2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disease51
Neoplasms5
Multiple Myeloma4
Prostatic Neoplasms4
Lung Neoplasms3
Anxiety Disorders2
Carcinoma, Non-Small-Cell Lung2
Gastroesophageal Reflux2
Hypertension2
Lung Diseases2

Trials

Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.